Absorption, Bioavailability, and Immunogenicity after Subcutaneous Administration: Evaluation of a Subcutaneous Platform within the Open Systems Pharmacology framework

PBPK & PBBM

QSP

Program strategies and efficiencies

Pellowe M, Selvaggio G, Benamara S, Dubbelboer I, Teutonico D, Chenel M, Sjögren E